RBCC Initiates Talks With Emerging Drug Therapy Co.

Posted: Published on February 29th, 2012

This post was added by Dr Simmons

MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--

Rainbow BioSciences, the biotech division of Rainbow Coral Corp. (OTCBB: RBCC.OB - News) announced today that it has initiated talks with a drug development company pursuing a promising new therapy for Parkinsons disease.

The market for Parkinson's disease drugs could reach a value of $3.75 billion by 2015, according to a 2011 report by business info provider Visiongain. New drugs and other products could significantly boost the Parkinson's treatment market and help advance the timeline for a cure for this debilitating disease.

RBCC is always searching for new partnerships, joint ventures, and possible acquisitions that could increase the companys revenues and exposure in the biotech industry. The company is working on agreements with rising stars in need of assistance in funding, marketing and distributing their projectsRBCCs specialty.

The company is exploring a possible deal with the drug therapy company as well as others as it pursues promising new opportunities for rapid growth.

For more information on Rainbow BioSciences, Rainbow Corals biotech division, please visit http://www.rainbowbiosciences.com/investors.

Rainbow BioSciences will develop new medical and research technology innovations to compete alongside companies such as Celgene Corp. (NASDAQ:CELG), Cardinal Health, Inc. (NYSE: CAH - News), Abbott Laboratories (NYSE:ABT) and Affymax, Inc. (NASDAQ:AFFY).

Follow us on Twitter atwww.twitter.com/RBCCinfo.

About Rainbow BioSciences

Rainbow BioSciences is a division of Rainbow Coral Corp. (OTCBB:RBCC). The company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visit our website at [www.rainbowbiosciences.com]. For investment information and performance data on the company, please visitwww.RainbowBioSciences.com/investors.

Read more:
RBCC Initiates Talks With Emerging Drug Therapy Co.

Related Posts
This entry was posted in Parkinson's Treatment. Bookmark the permalink.

Comments are closed.